Abstract
Purpose We investigated the influence of impaired renal function on fundus characteristics, pars-plana vitrectomy (PPV) details, and outcomes in patients with proliferative diabetic retinopathy (PDR).
Design a retrospective cohort study
Methods We investigated a consecutive series of PDR patients who underwent PPV. The diabetic complications, previous photocoagulation, intravitreal injections before PPV, ocular findings during PPV, surgical details, short-term visual outcome and post-PPV complications were recorded and compared between patients with and without impaired renal function.
Results 149 patients had normal renal function (67.7%) and 71 (32.3%) patients had impaired renal function, 85.4% of patients were identified with chronic kidney disease (CKD) during the preoperative assessment. Impaired renal function was related to hypertension (3.40[1.58-7.29], p=0.002), incomplete panretinal photocoagulation (PRP) (3.18[1.50-6.72], p=0.002), severe fibrovascular membrane (8.19[3.43-19.54], p<0.001), and extensive retinal vascular closure (3.40[1.54-7.52], p=0.002). There was a more frequent occurrence of severe intraoperative bleeding (56.3%, 32.2%, p=0.001), a higher percentage of intraocular subretinal fluid drainage (45.1%, 22.1%, p=0.008) in patients with impaired renal function. The percentage of patients whose visual acuity (VA) increased was similar between two groups (46.4%, 54.3%, p=0.34).
Conclusions In PDR patients, screening for CKD was required before PPV. PDR patients with impaired renal function tended to have more severe ischemic retinal conditions. Comparable PPV outcomes could be obtained in patients with and without impaired renal damage.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee of Beijing Tongren Hospital and adhered to the tenets of the Declaration of Helsinki. The requirement for informed consent was waived(TRECK2021-070).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Jipeng Li, Jun Xu and Meng Zhao are Ph.D degree
There was no conflict of interest.
The work was supported by The Fund for Beijing Science & Technology Development of TCM (No.JJ-2020-25)
Data Availability
The dataset(s) supporting the conclusions of this article is(are) available in zhao, meng (2022), “PDR patients and vitrectomy”, Mendeley Data, V1, doi: 10.17632/gdkpjnjv45.1
